ANDREW FIRLIK

Andrew Firlik stands as a prominent figure in the venture capital landscape, serving as a Managing Partner at Jazz Venture Partners. At the heart of his work is a profound commitment to investing in companies that push the boundaries of human potential through science and technology. Jazz Venture Partners, under his leadership, targets transformative opportunities in areas like neuroscience, human performance, digital health, artificial intelligence, biotech, mental health, and longevity.

Firlik's investment philosophy is deeply rooted in his unique background, blending extensive medical knowledge with sharp business acumen. He seeks out innovative startups that are developing evidence-based solutions to enhance cognitive function, physical capabilities, and overall well-being. His focus extends to companies leveraging cutting-edge research to create products and services that can truly make a difference in people's lives, from improving brain health to optimizing athletic performance and revolutionizing healthcare delivery.

Before co-founding Jazz Venture Partners, Andrew Firlik established a distinguished career as both a physician and an entrepreneur. He earned both his MD from Harvard Medical School and an MBA from Harvard Business School, providing him with a comprehensive understanding of both the scientific and commercial aspects of healthcare innovation. His early career included a background in neurosurgery, which instilled in him a deep appreciation for the complexities of the human brain and body. This medical foundation proved invaluable as he transitioned into entrepreneurship, co-founding and serving as CEO of HealthFinch, a company later acquired by Health Catalyst. Prior to that, he also co-founded and led Proteus Biomedical, which evolved into Proteus Digital Health, a pioneer in digital medicines.

Through Jazz Venture Partners, Firlik has been instrumental in backing a portfolio of companies poised to redefine their respective industries. While specific partner investments are often private, the firm's portfolio reflects his strategic vision, including investments in companies like Neurable, which focuses on brain-computer interfaces; Alto Neuroscience, developing precision psychiatry; AppliedVR, utilizing virtual reality for pain management; and Levels, which provides continuous glucose monitoring for metabolic health. These investments exemplify his dedication to supporting ventures that combine rigorous science with scalable technology to address significant human challenges.

Andrew Firlik's work at Jazz Venture Partners continues to shape the future of health and human performance. His ability to identify and nurture groundbreaking companies, coupled with his deep expertise across medical and technological domains, positions him as a visionary leader driving innovation that truly matters.